CINECA IRIS Institutional Research Information System

LAMBA, SIMONA ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.186
EU - Europa 3.014
AS - Asia 1.990
SA - Sud America 171
OC - Oceania 70
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.466
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.972
CN - Cina 1.056
IT - Italia 1.006
GB - Regno Unito 299
DE - Germania 285
JP - Giappone 251
FR - Francia 248
IE - Irlanda 166
CA - Canada 132
ES - Italia 131
KR - Corea 124
PL - Polonia 122
SE - Svezia 115
TW - Taiwan 86
UA - Ucraina 86
TR - Turchia 79
BE - Belgio 75
DK - Danimarca 75
FI - Finlandia 68
NL - Olanda 64
MX - Messico 63
HK - Hong Kong 55
IN - India 52
VN - Vietnam 52
AT - Austria 49
AU - Australia 47
CH - Svizzera 46
PE - Perù 45
BR - Brasile 41
IL - Israele 38
SG - Singapore 30
RO - Romania 29
CZ - Repubblica Ceca 28
CL - Cile 26
TH - Thailandia 25
NZ - Nuova Zelanda 23
IR - Iran 22
PT - Portogallo 22
GR - Grecia 19
NO - Norvegia 17
CO - Colombia 16
HU - Ungheria 16
EC - Ecuador 15
AR - Argentina 14
ID - Indonesia 14
MY - Malesia 14
SA - Arabia Saudita 14
RU - Federazione Russa 13
PH - Filippine 11
GY - Guiana 10
PS - Palestinian Territory 10
SN - Senegal 10
LB - Libano 9
KZ - Kazakistan 8
SK - Slovacchia (Repubblica Slovacca) 8
JO - Giordania 7
MO - Macao, regione amministrativa speciale della Cina 6
NI - Nicaragua 6
PR - Porto Rico 6
EG - Egitto 5
LV - Lettonia 5
NG - Nigeria 5
QA - Qatar 5
AE - Emirati Arabi Uniti 4
HR - Croazia 4
LT - Lituania 4
PK - Pakistan 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CY - Cipro 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
IQ - Iraq 2
MN - Mongolia 2
RS - Serbia 2
SV - El Salvador 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
EU - Europa 1
KE - Kenya 1
LK - Sri Lanka 1
MU - Mauritius 1
PA - Panama 1
TZ - Tanzania 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 9.466
Salva come PNG Salva come JPEG
Città #
Ann Arbor 806
Chandler 285
Beijing 252
Fairfield 201
Redwood City 153
Dublin 150
Houston 144
Guangzhou 130
Dearborn 124
Shanghai 120
Woodbridge 111
Ashburn 106
Milan 97
Cambridge 96
Seattle 94
Torino 89
Wilmington 82
Turin 73
Tokyo 66
Warsaw 61
Pisa 58
Villeurbanne 55
Nyköping 53
Jacksonville 51
Brussels 47
Fremont 45
Princeton 44
Taipei 43
Wuhan 40
Medford 39
Vienna 36
Lima 35
Nanjing 34
Buffalo 33
Hangzhou 33
New York 33
Rome 33
London 32
Barcelona 30
Carrara 30
Dundee 30
Toronto 29
Boston 28
Ithaca 28
Seoul 28
Stuttgart 28
Paris 26
Berlin 24
Dong Ket 23
Washington 23
Chicago 22
Jinan 22
Duncan 21
San Diego 21
Chengdu 20
Munich 20
Ottawa 20
Central District 17
Iowa City 17
Istanbul 17
Luni 17
Marcellus 17
Brooklyn 16
Rochester 16
Zhengzhou 16
Genoa 15
Toulouse 15
Changsha 14
Los Angeles 14
Xian 14
Chongqing 13
Falls Church 13
Florence 13
Naples 13
Santiago 13
Pittsburgh 12
Zurich 12
Changchun 11
Fuzhou 11
Jerusalem 11
Madrid 11
Norwalk 11
Oslo 11
Philadelphia 11
Phoenix 11
San Jose 11
Southend 11
Tianjin 11
Bologna 10
Central 10
Concepción 10
Redmond 10
San Francisco 10
Shenyang 10
Amsterdam 9
Gaza 9
Miami 9
Mountain View 9
Nashville 9
Polska 9
Totale 4.986
Salva come PNG Salva come JPEG
Nome #
High-dose Vitamin C enhances cancer immunotherapy 3.192
Adaptive mutability of colorectal cancers in response to targeted therapies 1.395
EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer 519
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 471
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer 390
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 351
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 289
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. 204
Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis 200
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 197
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone. 181
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 147
RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells. 143
Mutational profiling of kinases in glioblastoma. 140
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies 115
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer 109
Absence of AKT1 mutations in glioblastoma 106
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer 102
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 102
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. 100
Abstract 1163: Microenvironment targets in KRAS-mutated metastatic colorectal cancer 99
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 97
AKT1 (E17K) in human solid tumours 96
Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer 96
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF 91
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 90
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors 89
Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma 85
Mutational profile of GNAQQ209 in human tumors 71
Mutational profiling of Cancer Candidate genes in Glioblastoma, Melanoma and Pancreatic Carcinoma reveals a snapshot of their genomic landscapes 70
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 70
Targeted Knock-in of the Polymorphism rs61764370 Does Not Affect KRAS Expression but Reduces let-7 Levels 62
The prognostic IDH1 ( R132 ) mutation is associated with reduced NADP (+)-dependent IDH activity in glioblastoma 60
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 59
Ras Mutations in Cancer 51
Isogenic K-Ras mutant cancer cells: A novel platform for drug profiling 45
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance 12
Dual VEGFA/BRAF targeting boosts PD-1 blockade in melanoma through GM-CSF-mediated infiltration of M1 macrophages 8
Totale 9.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.880
article - articoli 0
book - libri 0
conference - conferenze 757
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019364 0 0 0 11 8 22 13 55 16 61 125 53
2019/2020771 41 30 40 89 57 103 100 39 64 74 82 52
2020/20212.077 57 93 203 214 173 192 254 145 183 171 125 267
2021/20222.695 273 270 286 345 180 159 195 199 207 151 234 196
2022/20232.447 159 157 200 188 151 283 247 220 263 161 247 171
2023/2024644 232 189 221 2 0 0 0 0 0 0 0 0
Totale 9.704